GB0804242D0 - Clopidogrel solution - Google Patents

Clopidogrel solution

Info

Publication number
GB0804242D0
GB0804242D0 GBGB0804242.6A GB0804242A GB0804242D0 GB 0804242 D0 GB0804242 D0 GB 0804242D0 GB 0804242 A GB0804242 A GB 0804242A GB 0804242 D0 GB0804242 D0 GB 0804242D0
Authority
GB
United Kingdom
Prior art keywords
clopidogrel solution
clopidogrel
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0804242.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rosemont Pharmaceuticals Ltd
Original Assignee
Rosemont Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosemont Pharmaceuticals Ltd filed Critical Rosemont Pharmaceuticals Ltd
Priority to GBGB0804242.6A priority Critical patent/GB0804242D0/en
Publication of GB0804242D0 publication Critical patent/GB0804242D0/en
Priority to PCT/GB2009/000527 priority patent/WO2009109741A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB0804242.6A 2008-03-07 2008-03-07 Clopidogrel solution Ceased GB0804242D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0804242.6A GB0804242D0 (en) 2008-03-07 2008-03-07 Clopidogrel solution
PCT/GB2009/000527 WO2009109741A1 (fr) 2008-03-07 2009-02-25 Solution de clopidogrel destinée à l’administration orale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0804242.6A GB0804242D0 (en) 2008-03-07 2008-03-07 Clopidogrel solution

Publications (1)

Publication Number Publication Date
GB0804242D0 true GB0804242D0 (en) 2008-04-16

Family

ID=39327687

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0804242.6A Ceased GB0804242D0 (en) 2008-03-07 2008-03-07 Clopidogrel solution

Country Status (2)

Country Link
GB (1) GB0804242D0 (fr)
WO (1) WO2009109741A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782455B3 (fr) * 1998-08-20 2000-09-15 Sanofi Sa Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
EP1888037A2 (fr) * 2005-05-10 2008-02-20 Elan Pharma International Limited Formulations de nanoparticules de clopidogrel

Also Published As

Publication number Publication date
WO2009109741A1 (fr) 2009-09-11

Similar Documents

Publication Publication Date Title
EP2280616A4 (fr) Body pour bébé
EP2257170A4 (fr) Tétrahydrofuropyridones
EP2285758A4 (fr) Emballage à jeter pour engrais-pesticide
EP2313147A4 (fr) Pince à broyer
ZA201007979B (en) Thienopyrimidines
GB0801600D0 (en) Microtrench
EP2233305A4 (fr) Traceur électrostatique
EP2285375A4 (fr) Spiroaza-indoles
GB0801589D0 (en) Mollusicide
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
GB0804242D0 (en) Clopidogrel solution
AU4098P (en) NPW2 Dianella tasmanica
AU3977P (en) PARV01 Myoporum parvifolium
AU3935P (en) DPV308 Dianella prunina
AU3972P (en) Tobruk xTriticosecale
GB0800104D0 (en) Dissolve-a-bottle
GB0800935D0 (en) Kjbjkbk
AU323550S (en) Sidechair
AU322905S (en) LED-Luminaire
AU2008371V (en) Berbee Dianella tasmanica
AU2008315V (en) DT5001 Dianella tasmanica
AU2008306V (en) LND01 Lomandra confertifolia
AU2008295V (en) Canobolas xTriticosecale
GB0800410D0 (en) Q-Box

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)